drugset / Trial / NCT03378284
A Study to Evaluate Safety, Tolerability, and PD of Tegoprazan on Healthy Male Volunteers
RandomizedParallel-groupOpen-labelBasic science
Summary
A randomized, open-label, active-controlled, multiple dose phase 1 clinical trial to evaluate safety, tolerability, and pharmacodynamics of tegoprazan after oral administration in healthy male volunteers
Timeline
- Start
- 2017-12-10
- Primary completion
- 2017-12-23
- Completion
- 2018-01-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Revaprazan | Unknown | — | Oral |
| Subject | Tegoprazan | Other / unclassified | — | Oral |
Indications
No indication recorded.